Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_4
2
50%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting1
unknown1
Completed1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (50.0%)
N/A2 (50.0%)

Trials by Status

recruiting125%
unknown125%
completed125%
enrolling_by_invitation125%

Recent Activity

1 active trials
Showing 4 of 4
enrolling_by_invitationnot_applicable

The Effect of Tranexamic Acid Vs Torniquet on Visual Clarity in Knee Arthroscopic ACL Reconstruction

NCT06781021
recruitingphase_4

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

NCT05957822
unknownnot_applicable

Arthroscopic Treatment Combine With TXA for Elbow Stiffness

NCT05138913
completedphase_4

TXA vs. Amicar in Total Knee and Hip Arthroplasty

NCT02030821

Clinical Trials (4)

Showing 4 of 4 trials
NCT06781021Not Applicable

The Effect of Tranexamic Acid Vs Torniquet on Visual Clarity in Knee Arthroscopic ACL Reconstruction

Enrolling By Invitation
NCT05957822Phase 4

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

Recruiting
NCT05138913Not Applicable

Arthroscopic Treatment Combine With TXA for Elbow Stiffness

Unknown
NCT02030821Phase 4

TXA vs. Amicar in Total Knee and Hip Arthroplasty

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4